Skip to main content
Fig. 5 | European Journal of Hybrid Imaging

Fig. 5

From: Early acquisition of [18F]FDOPA PET/CT imaging in patients with recurrent or residual medullary thyroid cancer is safe—and slightly better!

Fig. 5

A 65-year-old man (patient 3). All lesions were verified by biopsies as true positive. A Imaging 15 min p.i. showed focal 18F-FDOPA uptake corresponding to two cervical lymph nodes (SUVmax = 6) and three thoracic lymph nodes (SUVmax = 10). B 18F-FDOPA uptake was no longer evident 59 min p.i. in the two cervical lymph nodes, and uptake in the thoracic lymph nodes was reduced (SUVmax = 5)

Back to article page